Commitment to achieving net zero
Swedish Orphan Biovitrum Ltd (“Sobi”) is the UK subsidiary of Swedish Orphan Biovitrum AB, the parent company of the Sobi Group, headquartered in Stockholm, Sweden. The Sobi organisation spans more than 30 countries, delivering treatments to patients in over 70 countries across the globe.
As our parent-company is based within the European Union (EU), Sobi AB has an obligation to set and drive targets that are aligned with the Paris 1.5°C target to achieve net neutrality for the entire Group by 2050.
Our ambition is to reduce our operational GHG footprint (combined Scope 1 and 2 emissions) by 37.8% between 2023 and 2029. This means an absolute reduction of more than 700 CO2e in scope 1 and 2 emissions combined including estimated activity growth. This target is a verified SBTi near-term target.
We have also set a supplier engagement target to cover scope 3 emissions in alignment with SBTi's recommendations and verified by SBTi during 2025. Sobi aims for 65% of its suppliers to adopt Science-Based Targets (SBTs) between 2023 and 2029, focusing on Scope 3 categories that contribute the most to emissions; including purchased goods and services, and upstream transport and distribution. Categories 3.1, 3.2, and 3.4 are included in the target.
The UK subsidiary, Sobi Ltd, is separately committed to achieving net zero emissions within the UK by 2050.
Sobi Emissions Footprint
Baseline emissions are a record of the greenhouse gases (GHG) that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions.
Baseline emissions are the reference point against which emissions reduction can be measured.
Sobi’s baseline GHG emissions in tonnes CO2
Scope 1, 2 and 3 baseline year: 2013 | |
Scope 1: Direct emissions from Sobi’s own operations | 1053 |
Scope 2: Indirect emissions from Sobi’s own operations (market-based) | 815 |
Scope 3: indirect emissions that occur in Sobi’s value chain | 193,109 |
Sobi’s current GHG emissions in tonnes CO2
Reporting year: 2024 | |
Scope 1: Direct emissions from Sobi’s own operations | 1,097 |
Scope 2: Indirect emissions from Sobi’s own operations (market-based) | 771 |
Scope 3: indirect emissions that occur in Sobi’s value chain* | 251,456 |
Carbon Reduction Projects
Between the base year of 2023 and reporting year of 2024, emissions in scope 1 and 2 remained unchanged. Since the target was set at the end of 2024 none of the planned actions were implemented during the year. Hence, this development is in line with the expectation.
To drive future progress, Sobi has established a dedicated Climate Taskforce to drive the transition to a low- and zero-emission car fleet while providing guidance to entitles on reducing their carbon footprint through energy efficiency measures and switching to renewable energy. This initiative is complemented by the Global Travel Policy, which aims to minimise climate impact by limited travel or promoting smarter travel choices, such as prioritising ground transportation over air travel and opting for low- or zero-emission rental vehicles.
The Climate Taskforce is also exploring investments in energy-efficient facilities, while discussions with Sobi suppliers include opportunities to enhance energy management and transition renewable energy sources.
Sobi UK remains committed to reducing our emissions and achieving net zero emissions within the UK by 2050. Our carbon footprint is mainly caused by energy consumption in pharmaceutical manufacturing, business travel, supply chain logistics and the distribution of medicines. Environmental impacts from production and laboratories are mainly due to the use of energy, water and chemicals, waste generated and sewage discharge.
Reduction of water and energy consumption, management of chemicals, waste and emissions has been prioritised in Sobi's office and laboratory facilities.
In the UK, Sobi has made significant strides by sourcing 100% renewable energy for its UK office. Additional initiatives include reducing travel distances for meetings and introducing an electric and hybrid car scheme for UK employees.
More details on our global metrics, projects and performance related to climate and energy can be found in the section ESRS E1 Climate Change of our ‘Annual and Sustainability Report 2024’, available here.
Declaration and Sign Off
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard1 and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.2
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.3
This Carbon Reduction Plan has been reviewed and signed off by the UK company director.
Signed on behalf of Sobi Ltd
………………………………………………………………………..
Sharon Hall
Vice President & General Manager, UK & Republic of Ireland UK & Ireland
Date: September 2025
- https://ghgprotocol.org/standards/scope-3-standard
- https://www.gov.uk/government/collections/government-conversion-factors-for-company-reporting
- https://ghgprotocol.org/corporate-standard Sobi: Annual and sustainability report 2024. Available at: https://www.sobi.com/sites/sobi/files/pr/202503277259-1-1.pdf
Oct, 2025